Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
UTEC - The University of Tokyo Edge Capital Partners is a prominent venture capital firm established in 2004 and based in Tokyo, Japan. With over $1 billion in assets under management (AUM) across six funds, UTEC has built a robust portfolio of more than 150 startups, achieving significant milestones including 20 IPOs and 22 mergers and acquisitions. The firm is closely associated with the University of Tokyo, leveraging its academic connections to source innovative technologies and support transformative science and technology ventures. UTEC's reputation in the market is underscored by its strong track record in deep-tech investments, particularly in sectors such as biotech, healthcare, and physical sciences. The firm launched its latest fund, UTEC 6, in July 2025, with a capital commitment of approximately $326 million (JPY 47 billion), further solidifying its position as a key player in the venture capital landscape.
UTEC focuses its investments on three primary domains: Healthcare & Life Sciences, Information Technology, and Physical Sciences & Engineering. The firm operates as a seed-and-lead investor, providing substantial financial backing with check sizes ranging from $500,000 to $20 million. UTEC is committed to long-term support for its portfolio companies, offering assistance from pre-incorporation stages through to successful exits. This approach allows UTEC to nurture startups effectively, ensuring they have the resources and guidance needed to thrive in competitive markets. The firm emphasizes a bidirectional investment model, supporting Japanese startups in global markets while also facilitating the entry of international innovations into Japan. This strategy not only enhances the growth potential of its portfolio companies but also fosters cross-border collaboration and innovation.
UTEC boasts a diverse portfolio of over 165 companies worldwide, showcasing its commitment to investing in transformative technologies. Notable investments include 908 Devices, Fyusion, Agara, PeptiDream, and Mujin, among others. The firm has successfully guided 20 companies to public listings and facilitated 22 mergers and acquisitions, demonstrating its effectiveness in identifying and nurturing high-potential startups. UTEC's strong focus on deep-tech ventures has positioned it as a leader in the biotech and healthcare sectors, where it continues to seek out groundbreaking innovations that address significant global challenges. The firm's extensive network and collaboration with leading universities and research institutions further enhance its ability to source impactful technologies and support its portfolio companies.
Dr. Hiroshi Matsumoto - Managing Partner, with extensive experience in venture capital and a strong background in technology commercialization. Yuki Tanaka - Principal, focusing on investments in healthcare and life sciences, leveraging his expertise in medical technology. Akira Saito - Partner, specializing in physical sciences and engineering, with a track record of successful investments in deep-tech startups.
To pitch UTEC, founders should prepare a detailed presentation that outlines their business model and market opportunity. While specific submission guidelines are not provided, a well-structured pitch deck is essential for capturing the firm's interest. UTEC values thorough and compelling presentations that clearly articulate the startup's vision and potential.
In January 2024, UTEC made its latest investment, continuing its active engagement in the startup ecosystem. The firm recently launched its UTEC 6 fund in July 2025, with a commitment of $326 million, further enhancing its capacity to support innovative startups across various sectors.
UTEC primarily invests in the Seed and Series A stages of startup development. This focus allows the firm to support early-stage companies as they establish their market presence and develop their products.
Founders interested in pitching to UTEC should prepare a comprehensive presentation that outlines their business model, market opportunity, and team. While specific submission guidelines are not provided, a well-structured pitch deck is essential for capturing the firm's interest.
UTEC concentrates its investments in three key sectors: Healthcare & Life Sciences, Information Technology, and Physical Sciences & Engineering. This focus aligns with the firm's mission to back transformative science and technology.
UTEC typically invests between $500,000 and $20 million in its portfolio companies. This range allows the firm to provide substantial support to startups at various stages of their growth.
UTEC has a global investment strategy, focusing on markets in Europe, India, Japan, Singapore, and the United States. This geographic diversity enables the firm to tap into a wide array of innovative startups.
While specific details about the application process are not disclosed, founders are encouraged to reach out with their pitch materials. UTEC values thorough presentations that clearly articulate the startup's vision and potential.
UTEC offers hands-on support to its portfolio companies at every stage of their development. This includes access to professional knowledge, global networking opportunities, and guidance from experienced industry professionals.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.